Antal Rohit Desai is Director at PROCEPT BioRobotics Corp (PRCT). They have made 2 open-market trades across 1 company since 2021, most recently 2026-06-09.
CIK 0001881616
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $21.5M since 2021, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| APEN | 1,310,701 | $13.1M |
| PRCT | 38,467 | $676K |
| Total | $13.8M |
Shares reported on the most recent Form 4, priced at the 2026-06-10 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PRCT | BUY | 2026-03-05 | 2026-03-09 | $24.59 | $10.5M | -4.4% | -11.2% | +5.5% |
| PRCT | SELL · 10b5-1 | 2025-06-10 | 2025-06-12 | $62.93 | $9.4M | -3.0% | -3.0% | -37.5% |
| PRCT | SELL · 10b5-1 | 2025-06-03 | 2025-06-05 | $62.33 | $7.4M | -9.4% | -12.6% | -41.9% |
| PRCT | SELL · 10b5-1 | 2024-11-05 | 2024-11-07 | $96.33 | $19.2M | -1.8% | -2.9% | -22.5% |
| PRCT | SELL · 10b5-1 | 2024-09-10 | 2024-09-12 | $78.21 | $17.0M | -1.5% | -9.4% | +12.5% |
| PRCT | SELL · 10b5-1 | 2024-09-03 | 2024-09-05 | $75.77 | $15.3M | +4.8% | -8.5% | +30.6% |
| PRCT | BUY | 2021-09-17 | 2021-09-21 | $25.00 | $11.0M | -0.1% | +10.3% | -35.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.